E.M. Paradise
E.M. Paradise
Verified email at berkeley.edu
Title
Cited by
Cited by
Year
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
DK Ro, EM Paradise, M Ouellet, KJ Fisher, KL Newman, JM Ndungu, ...
Nature 440 (7086), 940-943, 2006
27132006
Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoids
Y Shiba, EM Paradise, J Kirby, DK Ro, JD Keasling
Metabolic engineering 9 (2), 160-168, 2007
2932007
High‐level production of amorpha‐4, 11‐diene in a two‐phase partitioning bioreactor of metabolically engineered Escherichia coli
JD Newman, J Marshall, M Chang, F Nowroozi, E Paradise, D Pitera, ...
Biotechnology and bioengineering 95 (4), 684-691, 2006
2602006
Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid
DK Ro, M Ouellet, EM Paradise, H Burd, D Eng, CJ Paddon, JD Newman, ...
BMC biotechnology 8 (1), 83, 2008
1702008
Redirection of flux through the FPP branch‐point in Saccharomyces cerevisiae by down‐regulating squalene synthase
EM Paradise, J Kirby, R Chan, JD Keasling
Biotechnology and bioengineering 100 (2), 371-378, 2008
1232008
Engineering triterpene production in Saccharomyces cerevisiae–β‐amyrin synthase from Artemisia annua
J Kirby, DW Romanini, EM Paradise, JD Keasling
The FEBS journal 275 (8), 1852-1859, 2008
1042008
The foxgloves (Digitalis) revisited
W Kreis
Planta Medica 83 (12/13), 962-976, 2017
182017
Genetically modified host cells and use of same for producing isoprenoid compounds
JD Keasling, EM Paradise, J Kirby
18*2006
Genetically modified host cells and use of same for producing isoprenoid compounds
Y Shiba, J Kirby, EM Paradise, JD Keasling
US Patent App. 12/063,831, 2009
172009
Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof
DK Ro, K Newman, EM Paradise, JD Keasling, M Ouellet, R Eachus, K Ho, ...
US Patent 8,163,980, 2012
102012
Genetically modified host cells and use of same for producing isoprenoid compounds
JD Keasling, J Kirby, EM Paradise
US Patent 10,435,717, 2019
22019
Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid
OM RO DK, EM PARADISE
BMC Biotechnol 8, 83, 2008
22008
Genetically modified host cells and use of same for producing isoprenoid compounds
JD Keasling, J Kirby, EM Paradise
US Patent App. 16/554,125, 2019
2019
Strain Engineering and Fermentation Process Development toward Supplying Semi-Synthetic Artemisinin. A Key Component of Antimalarial Combination Therapies
R Regentin, CJ Paddon, P Westfall, H Tsuruta, DJ Pitera, DJ Eng, ...
The 2008 Annual Meeting, 2008
2008
Targeting pathways for genetic manipulations in Saccharomyces cerevisiae for improving artemisinin acid production via 13C metabolic flux analysis
Y Tang, E Paradise, S Rodriguez, M Ouellet, J Chu, D Chen, R Chan, ...
The Annual Meeting and Exhibition 2007, 2007
2007
Engineering Saccharomyces Cerevisiae for High-level Terpenoid Production
EM Paradise
University of California, Berkeley, 2006
2006
Metabolic engineering of Saccharomyces cerevisiae for the production of isoprenoids.
EM Paradise
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 225, U222-U222, 2003
2003
利用基因工程酵母生产抗疟疾药物前体--青蒿酸
DK Ro, EM Paradise, M Ouellet, KJ Fisher, KL Newman, JM Ndungu, ...
The system can't perform the operation now. Try again later.
Articles 1–18